GeoWealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.27M Buy
5,863
+24
+0.4% +$8.9K 0.07% 159
2026
Q1
$1.71M Buy
5,839
+1,494
+34% +$491K 0.06% 180
2025
Q4
$1.52M Sell
4,345
-653
-13% -$221K 0.06% 198
2025
Q3
$1.62M Buy
4,998
+3,328
+199% +$1.04M 0.06% 202
2025
Q2
$650K Sell
1,670
-103
-6% -$41.4K 0.03% 350
2025
Q1
$772K Buy
1,773
+304
+21% +$122K 0.03% 328
2024
Q4
$542K Buy
1,469
+248
+20% +$104K 0.02% 452
2024
Q3
$635K Sell
1,221
-7
-0.6% -$3.74K 0.02% 418
2024
Q2
$665K Buy
1,228
+400
+48% +$211K 0.03% 360
2024
Q1
$429K Buy
828
+736
+800% +$366K 0.02% 480
2023
Q4
$43K Sell
92
-21
-19% -$9.71K ﹤0.01% 629
2023
Q3
$50K Buy
113
+52
+85% +$23.6K 0.01% 393
2023
Q2
$27K Buy
61
+17
+39% +$7.84K ﹤0.01% 356
2023
Q1
$20K Buy
+44
New +$20.9K ﹤0.01% 320

Other funds holding ELV

GeoWealth Management's ELV Position: Q2 2026 in Review

GeoWealth Management increased its Elevance Health (ELV) stake by 0.41% in Q2 2026, buying an estimated $8.9K and bringing the position to 5,863 shares worth $2.27M. The position accounts for 0.07% of the portfolio, ranked #159.

GeoWealth Management first reported a position in ELV in Q1 2023 and has held it in 14 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • GeoWealth Management held 5,863 shares of Elevance Health worth $2.27M as of Q2 2026.
  • GeoWealth Management bought 24 Elevance Health shares in Q2 2026, an estimated $8.9K.
  • Elevance Health made up 0.07% of GeoWealth Management's portfolio in Q2 2026, its #159 holding.
  • GeoWealth Management first reported a position in Elevance Health in Q1 2023 and has held it in 14 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on GeoWealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.